Clinical Trial Update: Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial is recruiting to evaluate endoscopic sleeve gastroplasty for obesity in patients with MASLD/MASH and related liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Liver Fibrosis
• Metabolic Dysfunction-associated Steatohep
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis
• Obesity

Snippet

Sponsor: Pichamol Jirapinyo, MD, MPH | Conditions: Obesity, Liver Diseases | NA | Status: RECRUITING